Literature DB >> 1347573

Spectrum of disease in persons with human immunodeficiency virus infection in the United States.

K M Farizo1, J W Buehler, M E Chamberland, B M Whyte, E S Froelicher, S G Hopkins, C M Reed, E D Mokotoff, D L Cohn, S Troxler.   

Abstract

OBJECTIVE: To describe the spectrum of disease in persons with human immunodeficiency virus (HIV) infection.
DESIGN: Retrospective survey of medical records.
SETTING: More than 50 clinics, hospitals, and private medical practices in nine US cities. PATIENTS: A total of 626 women and 7008 men 13 years of age or older with HIV infection who received medical care from January 1990 through March 1991 were consecutively enrolled. MAIN OUTCOME MEASURES: Any history of diseases in the 1987 case definition for the acquired immunodeficiency syndrome (AIDS), and during the 12-month period preceding enrollment (baseline period), the occurrence of other major diseases, hospitalizations, and results of CD4+ lymphocyte counts.
RESULTS: Thirty-two percent of persons met the 1987 case definition for AIDS. The occurrence of an AIDS-indicator disease during the baseline period ranged from 3% (33/1011) to 46% (1254/2748) among persons with CD4+ lymphocyte counts of 0.50 x 10(9)/L or greater and fewer than 0.20 x 10(9)/L (greater than or equal to 500 and less than 200 CD4+ lymphocytes per microliter), respectively, and, at comparable CD4+ lymphocyte levels, was similar among women compared with men, and among persons who reported intravenous drug use compared with men who reported male-to-male sex. The frequency of one or more other major infectious diseases (eg, other pneumonias, bacterial sepsis, pulmonary tuberculosis) ranged from 6% to 16% among persons with CD4+ lymphocyte counts of 0.50 x 10(9)/L or greater and fewer than 0.20 x 10(9)/L, respectively; these illnesses were also associated with a history of intravenous drug use. Among persons who did not meet the 1987 AIDS case definition, 30% of those with an available CD4+ lymphocyte count had fewer CD4+ cells than 0.20 x 10(9)/L, 8% had one or more major infectious diseases, and 14% had one or more hospital admissions.
CONCLUSIONS: For every person with AIDS at these sites, two additional persons with HIV infection were receiving medical care, many of whom had severe immunosuppression and a broad spectrum of serious HIV-related disease.

Entities:  

Mesh:

Year:  1992        PMID: 1347573

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  42 in total

1.  Continued risky behavior in HIV-infected youth.

Authors:  C Diamond; S Buskin
Journal:  Am J Public Health       Date:  2000-01       Impact factor: 9.308

2.  A time to be born.

Authors:  M Anderka; E R Declercq; W Smith
Journal:  Am J Public Health       Date:  2000-01       Impact factor: 9.308

3.  Sources of prenatal care data and their association with birth outcomes of HIV-infected women.

Authors:  B J Turner; J Cocroft; C J Newschaffer; W W Hauck; T R Fanning; M Berlin
Journal:  Am J Public Health       Date:  2000-01       Impact factor: 9.308

4.  Survival patterns among HIV+ individuals based on health care utilization.

Authors:  K J Welch; A Morse
Journal:  J Natl Med Assoc       Date:  2001-06       Impact factor: 1.798

5.  Estimates of US children exposed to alcohol abuse and dependence in the family.

Authors:  B F Grant
Journal:  Am J Public Health       Date:  2000-01       Impact factor: 9.308

6.  Factors predicting completion of a home visitation program by high-risk pregnant women: the North Carolina Maternal Outreach Worker Program.

Authors:  M Navaie-Waliser; S L Martin; M K Campbell; I Tessaro; M Kotelchuck; A W Cross
Journal:  Am J Public Health       Date:  2000-01       Impact factor: 9.308

7.  A two-stage sampling method for clinical surveillance of individuals in care for HIV infection in the United States.

Authors:  Patrick S Sullivan; John M Karon; Faye E Malitz; Stephanie Broyles; Eve D Mokotoff; Susan E Buskin; Patricia L Fleming
Journal:  Public Health Rep       Date:  2005 May-Jun       Impact factor: 2.792

8.  Durability of adherence to antiretroviral therapy on initial and subsequent regimens.

Authors:  Edward M Gardner; William J Burman; Moises E Maravi; Arthur J Davidson
Journal:  AIDS Patient Care STDS       Date:  2006-09       Impact factor: 5.078

9.  HIV behavioral surveillance in the U.S.: a conceptual framework.

Authors:  Amy Lansky; Patrick S Sullivan; Kathleen M Gallagher; Patricia L Fleming
Journal:  Public Health Rep       Date:  2007       Impact factor: 2.792

Review 10.  Does intravenous immune globulin have a role in HIV-infected patients?

Authors:  P L Yap
Journal:  Clin Exp Immunol       Date:  1994-07       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.